Tag: Diabetes: Type II
Aspirin Use Doesn’t Cut Cancer Incidence in Older T2DM Patients
In subgroup analyses, reduced incidence of cancer seen in participants aged younger than 65 years
HbA1c Targets Should Be Personalized in Type 2 Diabetes
Target HbA1c 7% to 8% for most patients with T2DM; deintensification of tx with HbA1c <6.5%
Elevated NT-proBNP Found to Up Cardiovascular Risk in T2DM
Independently linked to major cardiovascular events, especially heart failure hospitalization
Strong Link Identified Between T2DM and Parkinson’s Disease
Findings in large cohort study based in the United Kingdom
Cancer Development Linked to Increased Diabetes Risk
Increased risk of subsequent diabetes independent of traditional diabetes risk factors
Inverse Link for Plasma 25(OH)D Concentration, Risk of T2DM
Each 10 ng/mL higher 25(OH)D concentration associated with hazard ratio of 0.64 for diabetes
Semaglutide Found to Be Effective Against Type 2 Diabetes
The once-weekly glucagon-like peptide 1 receptor agonist cuts HbA1c, body weight
Lesbian, Bi Women More Likely to Develop T2DM at Younger Age
Correlation between sexual orientation and type 2 diabetes is mediated by body mass index
Type 2 Diabetes Ups Risk of Renal Cancer in Women, but Not Men
Association strongest in patients with diabetes duration of five years or less
Community Health Worker-Led Intervention Beneficial in T2DM
Volunteer peer leader program linked to lasting improvements in HbA1c, fewer depressive symptoms